Readystate Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$806K Buy
+6,700
New +$774K 0.04% 310
2025
Q2
Sell
-35,000
Closed -$3.14M 816
2025
Q1
$3.14M Buy
35,000
+3,900
+13% +$364K 0.1% 209
2024
Q4
$3.09M Sell
31,100
-74,800
-71% -$7.71M 0.1% 219
2024
Q3
$12M Buy
105,900
+92,700
+702% +$11M 0.22% 191
2024
Q2
$1.63M Sell
13,200
-107,300
-89% -$13.8M 0.05% 254
2024
Q1
$15.9M Buy
120,500
+117,800
+4,363% +$14.5M 0.22% 80
2023
Q4
$294K Buy
+2,700
New +$280K 0.01% 514
2023
Q2
Sell
-2,800
Closed -$298K 365
2023
Q1
$298K Buy
+2,800
New +$302K 0.03% 275

Other funds holding MRK

Readystate Asset Management's MRK Position: Q2 2025 in Review

Readystate Asset Management sold out of Merck (MRK) in Q2 2025, closing a stake of 5,599 shares — an estimated $503K sold.

Readystate Asset Management first reported a position in MRK in Q3 2024 and held it in 3 quarters. The position peaked at $1.38M in Q4 2024. 3,327 funds tracked by Wall St. Rank hold MRK as of Q2 2025.

  • Readystate Asset Management reported no remaining Merck position as of Q2 2025 after selling out during the quarter.
  • Readystate Asset Management sold 5,599 Merck shares in Q2 2025, an estimated $503K.
  • Readystate Asset Management first reported a position in Merck in Q3 2024 and held it in 3 quarters.
  • Readystate Asset Management's Merck position peaked at $1.38M in Q4 2024.
  • 3,327 funds tracked by Wall St. Rank held Merck as of Q2 2025.

Based on Readystate Asset Management's 13F filing for Q2 2025, filed 7 Aug 2025.